×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
复旦大学上海医学院 [6]
湖南大学 [5]
中国医学科学院 北京... [5]
重庆大学 [3]
武汉大学 [3]
过程工程研究所 [2]
更多...
内容类型
期刊论文 [31]
发表日期
2019 [10]
2018 [4]
2017 [2]
2016 [4]
2015 [3]
2014 [3]
更多...
学科主题
生命有机化学 [1]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共31条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer
期刊论文
THERANOSTICS, 2019, 卷号: 9, 期号: 14
作者:
Yang, Yongzhi
;
Misra, Biswapriya B.
;
Liang, Lei
;
Bi, Dexi
;
Weng, Wenhao
收藏
  |  
浏览/下载:33/0
  |  
提交时间:2019/12/05
colorectal cancer
gut
microbiome
metabolomics
biomarkers
Safety and efficacy of oral nemonoxacin versus levofloxacin in treatment of community-acquired pneumonia: A phase 3, multicenter, randomized, double-blind, double-dummy, active-controlled, non-inferiority trial
期刊论文
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2019, 卷号: 52, 期号: 1
作者:
Yuan, Jinyi
;
Mo, Biwen
;
Ma, Zhuang
;
Lv, Yuan
;
Cheng, Shih-Lung
收藏
  |  
浏览/下载:32/0
  |  
提交时间:2019/12/05
Clinical outcome
Community-acquired pneumonia
Levofloxacin
Nemonoxacin
Randomized controlled trial
Safety
Safety and efficacy of oral nemonoxacin versus levofloxacin in treatment of community-acquired pneumonia: A phase 3, multicenter, randomized, double-blind, double-dummy, active-controlled, non-inferiority trial
期刊论文
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2019, 卷号: 52, 期号: 1
作者:
Perng, Wann Cherng
;
Chuang, Yin Ching
;
Wu, Xiaoju
;
Xiao, Yi
;
Shen, Ce
收藏
  |  
浏览/下载:49/0
  |  
提交时间:2019/12/05
Clinical outcome
Community-acquired pneumonia
Levofloxacin
Nemonoxacin
Randomized controlled trial
Safety
Safety and efficacy of oral nemonoxacin versus levofloxacin in treatment of community-acquired pneumonia: A phase 3, multicenter, randomized, double-blind, double-dummy, active-controlled, non-inferiority trial
期刊论文
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2019, 卷号: 52, 期号: 1
作者:
Yuan, Jinyi
;
Mo, Biwen
;
Ma, Zhuang
;
Lv, Yuan
;
Cheng, Shih-Lung
收藏
  |  
浏览/下载:50/0
  |  
提交时间:2019/12/05
Clinical outcome
Community-acquired pneumonia
Levofloxacin
Nemonoxacin
Randomized controlled trial
Safety
ASPP2 enhances chemotherapeutic sensitivity through the down-regulation of XIAP expression in a p53 independent manner in hepatocellular carcinoma.
期刊论文
Biochemical & Biophysical Research Communications, 2019, 卷号: Vol.508 No.3, 页码: 769-774
作者:
Yang, Tongwang
;
Gao, Yuxue
;
Liu, Daojie
;
Wang, Yang
;
Wu, Jing
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/12/17
LIVER
cancer
*CHEMOTHERAPY
(Cancer)
*DOWNREGULATION
*TRANSCRIPTION
factors
*REVERSE
transcriptase
polymerase
chain
reaction
ASPP2 enhances chemotherapeutic sensitivity through the down-regulation of XIAP expression in a p53 independent manner in hepatocellular carcinoma
期刊论文
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 卷号: Vol.508 No.3, 页码: 769-774
作者:
Yang, Tongwang
;
Gao, Yuxue
;
Liu, Daojie
;
Wang, Yang
;
Wu, Jing
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/12/17
XIAP
ASPP2
P53
Hepatocellular carcinoma
Apoptosis
Chemoresistance
New therapy with XLQ((R)) to suppress chronic prostatitis through its anti-inflammatory and antioxidative activities
期刊论文
JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 卷号: 234, 期号: 10, 页码: 17570-17577
作者:
Yang, Feiya
;
Meng, Lingquan
;
Han, Panpan
;
Chen, Dexi
;
Wang, Mingshuai
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2019/12/11
anti-inflammation
antioxidation
chronic prostatitis
signaling
pathways
XLQ((R))
ASPP2 enhances chemotherapeutic sensitivity through the down-regulation of XIAP expression in a p53 independent manner in hepatocellular carcinoma
期刊论文
Biochemical and Biophysical Research Communications, 2019, 卷号: Vol.508 No.3, 页码: 769-774
作者:
Tongwang Yang
;
Yuxue Gao
;
Daojie Liu
;
Yang Wang
;
Jing Wu
收藏
  |  
浏览/下载:10/0
  |  
提交时间:2019/12/13
XIAP
ASPP2
P53
Hepatocellular
carcinoma
Apoptosis
Chemoresistance
Safety and efficacy of oral nemonoxacin versus levofloxacin in treatment of community-acquired pneumonia: A phase 3, multicenter, randomized, double-blind, double-dummy, active-controlled, non-inferiority trial
期刊论文
2019, 卷号: 52, 期号: 1, 页码: 35-44
作者:
Yuan, Jinyi
;
Mo, Biwen
;
Ma, Zhuang
;
Lv, Yuan
;
Cheng, Shih-Lung
收藏
  |  
浏览/下载:30/0
  |  
提交时间:2020/01/03
Clinical outcome
Community-acquired pneumonia
Levofloxacin
Nemonoxacin
Randomized controlled trial
Safety
New therapy with XLQ((R)) to suppress chronic prostatitis through its anti-inflammatory and antioxidative activities
期刊论文
2019, 卷号: 234, 期号: 10, 页码: 17570-17577
作者:
Yang, Feiya
;
Meng, Lingquan
;
Han, Panpan
;
Chen, Dexi
;
Wang, Mingshuai
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2020/01/03
anti-inflammation
antioxidation
chronic prostatitis
signaling pathways
XLQ((R))
©版权所有 ©2017 CSpace - Powered by
CSpace